Results 161 to 170 of about 9,772 (228)

Practice-Based Consensus Amongst Indian Neurologists: Adopting Remote Electrical Neuromodulation for Effective Management of Migraine. [PDF]

Adv Ther
Chowdhury D, Chaudhuri JR, Passi P, Reddi R, Anand R, Singh S, Banerjee TK, Banerjee TK, Sharma V, Dhore MR, Charugulla SN, Kotak BP, Singh S.   +12 more
europepmc   +1 more source

Triple network disruption in medication overuse headache: functional signatures and clinical impact. [PDF]

J Headache Pain
Demichelis G, Fedeli D, Ciullo G, Medina Carrion JP, D'Amico D, Erbetta A, Gianeri R, Ferraro S, Montisano DA, Guastafierro E, Bruzzone MG, Grisoli M, Raggi A, Grazzi L, Nigri A.   +14 more
europepmc   +1 more source

Geriatric Migraine, Geroscience, and Sustainable Development Goals: Bridging Clinical Complexity and Public Health Priorities. [PDF]

J Clin Med
Tana C, Kodounis M, Ornello R, Raffaelli B, Messina R, Wells-Gatnik W, Waliszewska-Prosół M, Sacco S, Onan D, Martelletti P.   +9 more
europepmc   +1 more source

Comparing eptinezumab with onabotulinumtoxinA in the treatment of chronic migraine: a real-world evidence study. [PDF]

J Headache Pain
Scuteri D, Pagliaro M, Iannacchero R, Trimboli M, Lawrence GW, Bagetta G, Corasaniti MT.   +6 more
europepmc   +1 more source

The Burden of Analgesics Overprescription for Chronic Headache: Impacts on Patients, Healthcare System and Countries. [PDF]

J Multidiscip Healthc
Alshareef MH, Alsanosi SM.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Safety profile of the triptans

Expert Opinion on Drug Safety, 2003
The triptans are 5-HT(1B/1D) agonists used as migraine and cluster-specific agents. Seven are in commercial use worldwide; in order of release these are sumatriptan, zolmitriptan, rizatriptan, naratriptan, almotriptan, frovatriptan and eletriptan. Sumatriptan has been in clinical use since 1991, and although postmarketing studies have stimulated much ...
David Millson
exaly   +3 more sources

Triptans—Why Once?

Headache, 2006
Objective.—To evaluate triptan use patterns in a large Israeli HMO district. Background.—Triptans, 5HT 1B/1D agonists, provide an effective and safe relief of headache and accompanying symptoms during an acute migraine attack.
Gal Ifergane, Pesach Shvartzman
exaly   +3 more sources

Triptans

Psychosomatics, 2002
Triptans are potent serotonin (5-HT) 1B/1D receptor agonists used to abort and treat migraine headaches. Although the triptans share pharmacodynamic characteristics at 5-HT(1B/1D) receptors, they differ pharmacokinetically. This column reviews how the triptans are metabolized. Generally, the triptans are metabolized by phase I monoamine oxidases (MAOs)
Scott C, Armstrong, Kelly L, Cozza
openaire   +2 more sources